BL Pharmtech (A065170) Stock Overview
Manufactures, retails, imports, and exports health functional foods in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
A065170 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
BL Pharmtech Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩5,000.00 |
| 52 Week High | ₩7,870.00 |
| 52 Week Low | ₩376.00 |
| Beta | 3.52 |
| 1 Month Change | 819.12% |
| 3 Month Change | 655.29% |
| 1 Year Change | 688.64% |
| 3 Year Change | 92.31% |
| 5 Year Change | -4.15% |
| Change since IPO | -67.62% |
Recent News & Updates
Recent updates
Is BL Pharmtech (KOSDAQ:065170) A Risky Investment?
Jan 07
BL Pharmtech (KOSDAQ:065170) Is Making Moderate Use Of Debt
Apr 02Here's Why BL Pharmtech (KOSDAQ:065170) Can Afford Some Debt
Dec 18BL Pharmtech (KOSDAQ:065170) Has Debt But No Earnings; Should You Worry?
Sep 03Some Confidence Is Lacking In BL Pharmtech Corp.'s (KOSDAQ:065170) P/S
May 21Is BL Pharmtech (KOSDAQ:065170) A Risky Investment?
Mar 07Reflecting on Next Bt's (KOSDAQ:065170) Share Price Returns Over The Last Three Years
Mar 14Does Next Bt (KOSDAQ:065170) Have A Healthy Balance Sheet?
Jan 20
Next Bt's (KOSDAQ:065170) Shareholders Are Down 43% On Their Shares
Nov 28Shareholder Returns
| A065170 | KR Personal Products | KR Market | |
|---|---|---|---|
| 7D | 80.8% | -1.7% | -3.0% |
| 1Y | 688.6% | 39.3% | 94.4% |
Return vs Industry: A065170 exceeded the KR Personal Products industry which returned 39.3% over the past year.
Return vs Market: A065170 exceeded the KR Market which returned 94.4% over the past year.
Price Volatility
| A065170 volatility | |
|---|---|
| A065170 Average Weekly Movement | 28.8% |
| Personal Products Industry Average Movement | 5.9% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in KR Market | 12.8% |
| 10% least volatile stocks in KR Market | 2.9% |
Stable Share Price: A065170's share price has been volatile over the past 3 months compared to the KR market.
Volatility Over Time: A065170's weekly volatility has increased from 20% to 29% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 12 | Hyo-Lim Lee | www.blpharmtech.com |
BL Pharmtech Corp. manufactures, retails, imports, and exports health functional foods in South Korea. It is also involved in biotechnology business, as well as manufacture of cosmetics. The company was formerly known as Next BT Co., Ltd.
BL Pharmtech Corp. Fundamentals Summary
| A065170 fundamental statistics | |
|---|---|
| Market cap | ₩133.39b |
| Earnings (TTM) | -₩6.02b |
| Revenue (TTM) | ₩6.98b |
Is A065170 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A065170 income statement (TTM) | |
|---|---|
| Revenue | ₩6.98b |
| Cost of Revenue | ₩2.98b |
| Gross Profit | ₩4.00b |
| Other Expenses | ₩10.02b |
| Earnings | -₩6.02b |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -225.59 |
| Gross Margin | 57.31% |
| Net Profit Margin | -86.26% |
| Debt/Equity Ratio | 20.5% |
How did A065170 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/02/08 06:22 |
| End of Day Share Price | 2026/02/06 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
BL Pharmtech Corp. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Taehyeong Kim | KB Securities Co., Ltd. |